{"name":"Aravive, Inc.","slug":"aravive-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Paclitaxel (Pac)","genericName":"Paclitaxel (Pac)","slug":"paclitaxel-pac","indication":"Metastatic carcinoma of the ovary","status":"marketed"}]}],"pipeline":[{"name":"Paclitaxel (Pac)","genericName":"Paclitaxel (Pac)","slug":"paclitaxel-pac","phase":"marketed","mechanism":"Paclitaxel stabilizes microtubules by binding to β-tubulin, preventing their depolymerization and causing cell cycle arrest and apoptosis in cancer cells.","indications":["Metastatic carcinoma of the ovary","Breast cancer (metastatic and adjuvant)","Non-small cell lung cancer","Kaposi's sarcoma","Gastric adenocarcinoma"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNOWpYeU5zaFZNaUR3QTNtN0FNemc1M0dORmt2VW52QWplYktBdW9mVjdtSms4azhNaUhIdGNWVFVQSnEzLUhwMFRTZUZac045dnhqaHRXMFJjVkJiMzlKV0xoaFRhQURYMkstRXlMcHpLdnFXZzEtRl9idGlYME5lTU9QTWZ4NXZRZVktb0N2SkdHUVptNG1XdzNJbGhOWElqTERXNw?oc=5","date":"2025-05-06","type":"pipeline","source":"CytoDyn Inc.","summary":"CytoDyn Appoints Biotech Veteran Robert E. Hoffman as Chief Financial Officer - CytoDyn Inc.","headline":"CytoDyn Appoints Biotech Veteran Robert E. Hoffman as Chief Financial Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxQdEtnSzFQX2syTU1jV0dGM2IzR0F4WDlnV3JUcjFFSW1pQjVZSUZSV01JaXpTN2d5SWlYaUtHSVQ5dzRwcGNEXzlRY3JMaXhGeEVVcVVQdFhDUWFCZXM2YkY4RTBOLU05bm1MQXNIUWExY1BaYndCUklKMW5oeE8wcU5SNVlQTFktS3ZIcU1BVUlYeDRjS203WnFYQVlOY3BWTVFjclJvNGwtVjN3Yi00RG15ZF8?oc=5","date":"2024-08-13","type":"deal","source":"Pharmaceutical Technology","summary":"Baxter signs over kidney care arm to investment firm in $3.5bn deal - Pharmaceutical Technology","headline":"Baxter signs over kidney care arm to investment firm in $3.5bn deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2wFBVV95cUxPYXZBNS0xcjI1ejhLZzFJd084RllTTjZvRXVZN1d3anhlR2FBbkc5c3B2dVdvdmR4VXdkM2VjUlRVakxmcE9XdFRZYWJOOVd1QTZTZzBRRnVWUzdBa09keHR3VEEyMnlBVEE3YWxqekt3ek5XcnlBVkd2bHowRjBlVV9vWVYtTUZpZmhyNEYyNERDSFczcGRlbXhVZ1FZVElINWZLYnY3YkstU1lMWWxGX0JTRi1jQ25Nd0JXcFU5ZUVORjFfZnY2anhMU18zckdRWmplWFQyTkJjV1E?oc=5","date":"2024-04-23","type":"pipeline","source":"Business Wire","summary":"CORRECTING and REPLACING PharmaEssentia Appoints Robert Geller, M.D. as Head of Medical - Business Wire","headline":"CORRECTING and REPLACING PharmaEssentia Appoints Robert Geller, M.D. as Head of Medical","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE9FcEVOZjE1S0lNckFVRl9LWjNrSWFFSTRmYXBTdnpuQ0dyS3hoVmZFZFZGV2FkTG9MVlV2WUluNkh0eWRyY3l3SjRTTEhxVVZvTW5tMTYycmFTaTU1U09NbWN6OEpuLVE1eUZ1aTZiMFB1TDltVE45NA?oc=5","date":"2024-03-06","type":"deal","source":"Pharmaceutical Technology","summary":"Akari Therapeutics enters merger deal with Peak Bio - Pharmaceutical Technology","headline":"Akari Therapeutics enters merger deal with Peak Bio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxNMDF6Ml9kclJnZWNIbmxULVFjTm9HdWkyX19SRzgwallBeVU1TjZWRHozS2RrVDlab3FRTzdUTEtnRHpHRDRWeHpENHEtNlNhc1JkT0F4V0toT3U1ZXh0S1hBOW15ZFM2ZmdwdzNYQ2lpSUlSaUxzLW1NNFpoZVI3SlJqNmVzR3dXc0NCSkFJOTFDQQ?oc=5","date":"2024-01-19","type":"regulatory","source":"The Business Journals","summary":"Houston biotech company Aravive to delist from Nasdaq, approves liquidation - The Business Journals","headline":"Houston biotech company Aravive to delist from Nasdaq, approves liquidation","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxPNnZTcmpjeWpwZm5VNTQ3UXhXbnJyUjBKYm8tMlZ1blVHNGYyeDA4aVJNZGlZWmpENlNXRnlITnBKaWxtOGhrb01ERlh4Yi1nZi1icGljT1V4em1Xd1RpbGlKbnRucFhmd1laR3o0Sm1RLTB4V2VUS2RIMnNZdDd6Z1BTZWhMOUk3NWt1WGg4LWlZa2RMU2l4ZENQWVBSako1Vm9OM3ZZRzNJUUNnRmtrclBVNUt5M0o1Q2VJTkRnX2JZejlQ?oc=5","date":"2024-01-17","type":"pipeline","source":"globenewswire.com","summary":"Aravive, Inc. to Delist from The Nasdaq Stock Market - globenewswire.com","headline":"Aravive, Inc. to Delist from The Nasdaq Stock Market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxNQzAxRENEZVAtZkxVTHlSNm84dTRqSDlkbHd1a09PaUFtb3g2SnlKcXB5VkxwanRPSEdtci1yVFRwN3dKRTEya1ZHd1FUS3hGWFVsa0V5bDlTQ3VhQlg5aGNpN1l5UXVsdDNwdXRYaVcwVG5WVE9IdUhSZXlOS3RhaTNaOVlBSkpmS2FUNkFERVY4TTk0N2NNR3l1d09OUQ?oc=5","date":"2023-08-22","type":"pipeline","source":"Fierce Biotech","summary":"Aravive, weeks from liquidation, lays off 70% of its staff as it seeks a savior - Fierce Biotech","headline":"Aravive, weeks from liquidation, lays off 70% of its staff as it seeks a savior","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxQZFVNZjlUZ0xsNWUyempLMTAtQnE2NWI5RUEzMXNMU3pyRDRzMFlEOGxzT2pJcWxQNktLLTRxYlhFUjhEOXRrc2VmREpodUx5VEI5VzJjRWVfc0I2Y0JUUUVZYWJOMU5Lc2FwTmxwdk9HZk1KeEFnNlJTNk9YMnc1NjRTRWtlUHpDUW1WalZMcWREN2hDaUk4?oc=5","date":"2023-05-17","type":"pipeline","source":"openPR.com","summary":"Ovarian Cancer Pipeline Assessment (2023 Updates) | In-depth - openPR.com","headline":"Ovarian Cancer Pipeline Assessment (2023 Updates) | In-depth","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxNN3BQNEZKZWc0WmM0cWJERWNIWWNhRWRnOUh4Z2tndUdkUTRRazhmczI4N2Q5VmJlR0pOckVLcU5HS3RBT2Z3aEtUcnlFcnFia3lLM3lNTk9kQ3lwNV9sYURxaVJsdGd4dkJUTFhRUVhBVzdPa1NGZWJ3YTdBNmdhbWZFb1J2YkVtQTFQR1NyckFfLU1VckRsdnB6dUdSY0MtRnNsenZfc1RHeWpGS21FTS1vZU12X1UxeWhuUmFxSGd5WmEtMU45blY3eTNFVE0wVWxZa0NhSUI?oc=5","date":"2022-08-06","type":"pipeline","source":"SynBioBeta","summary":"Twist Bioscience Adds Ray Tabibiazar, M.D., as Senior Vice President, Corporate Development and Business Strategy - SynBioBeta","headline":"Twist Bioscience Adds Ray Tabibiazar, M.D., as Senior Vice President, Corporate Development and Business Strategy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9XNE1HSGE3U0U1Q3l4OG1SeFk5UWpSd0d4TnZDRlRqamhhRjJacXB6M01SbUt2VEgzRTNCYVk2eWFrb1FDTFBwd0JURGhaZ1lzdEFzMXV3c1JrMzFoMHRr?oc=5","date":"2019-12-22","type":"pipeline","source":"ChartMill","summary":"ARAV Stock Price, Quote & Chart | Aravive Inc (NASDAQ:ARAV) - ChartMill","headline":"ARAV Stock Price, Quote & Chart | Aravive Inc (NASDAQ:ARAV)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxPVEU4cGZVNW12Q2VvTUJCZThVNWlQQ0w2dWxVYUMzdXBYTHBXWkZZYXhoeXVoSnR6RG5fZzA3eXcwV0Mwa2RKM2FaOG1rT08yRzhmaktxWGliNjFSWDFJRlJjR2czY3A0WEhpVFBkeFJSR1pUY3E5YmF5RVpTUk95MzdGVHBfaDNhd1MtYnl5Mld2cUhjb1lfaVVCRUZkZ3hhLTNEdnhuQWYtcjd5MVNrZg?oc=5","date":"2018-10-24","type":"pipeline","source":"Fierce Biotech","summary":"Ray Tabibiazar departs Aravive to head up development at Twist Bioscience - Fierce Biotech","headline":"Ray Tabibiazar departs Aravive to head up development at Twist Bioscience","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNMmhZZ212WUszMEx4dFdVdVFQb0MxaWNQVHBJOFpGbUJuOWdYcmk4Z2xMWVdnaHU2WDlmNnVQWUs3bU9nTzRvMV91MFJFMnA2NEQ1TkpsRFlrdkJQWkdhSlRSTkk4Y2MyZF9pUlQ2eXNvNVNVd0JHY1d6NGdGRE55V2l4NV8yLWEwakRES0oxbmNqMkVQV2FYV0NSRDA?oc=5","date":"2018-06-05","type":"deal","source":"BioPharma Dive","summary":"Versartis stock climbs on reverse merger with Aravive - BioPharma Dive","headline":"Versartis stock climbs on reverse merger with Aravive","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}